Skip to content
Open access

Familial Multicystic Dysplastic Kidney Associated with HNF1B Mutation: A Sibling Case Report

Oct 2026 · European Journal of Medical and Health Research · 0 citations · 9 references

Abstract

Background: HNF1B-related disease is an autosomal dominant disorder caused by mutations or whole-gene deletions in the hepatocyte nuclear factor 1-beta (HNF1B) gene on chromosome 17q12, encoding a transcription factor essential for kidney, pancreas, liver, and urogenital development. It is the most frequent monogenic cause of congenital anomalies of the kidney and urinary tract (CAKUT), accounting for 10–30% of cases. Renal cysts (50%) and multicystic dysplastic kidney (MCDK) (37.5%) are the most common renal phenotypes. The most frequent genetic alteration is a 17q12 microdeletion (40–61.5%). The disease shows extreme phenotypic variability and incomplete penetrance. Case Presentation: We report two siblings with MCDK. Both parents had normal renal ultrasound and no history of renal cysts; they were initially considered eligible as kidney donors. Genetic testing of the affected siblings identified a heterozygous pathogenic variant in HNF1B. Parental genetic testing was recommended to determine transmission mode and recurrence risk. Discussion: This familial case is consistent with incomplete penetrance and variable expressivity. Parents without renal cysts may still carry a pathogenic HNF1B variant and transmit it with a 50% recurrence risk. De novo mutations or germline mosaicism are also possible. Two affected siblings strongly suggest an inherited mechanism. Parental genetic testing is essential. Extrarenal manifestations (diabetes, pancreatic, genital malformations) should be systematically evaluated. Early recognition enables tailored surveillance and reproductive planning. Conclusion: This case highlights the importance of considering HNF1B- related disease in familial CAKUT. Absence of renal cysts in parents does not rule out an inherited mutation. Genetic testing (sequencing and MLPA) is essential to establish transmission, recurrence risk, and management. A multidisciplinary approach involving nephrology, genetics, and endocrinology is recommended.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.